Key points from article :
Reservoir Neuroscience secured $4 million to develop new therapies for age-related neurodegeneration.
Funds to design novel class of drugs to restore health to the brain’s blood vessels and rejuvenate the aging brain.
Developed a first-in-kind compound that reverses blood vessel disease and repairs the blood-brain barrier.
Vascular decline affects most people as they age, making it a crucial target.
“This approach will be effective not only as a single therapy, but also has broader potential for a wide-variety of age-related diseases”, - Aaron Friedman, CEO of Reservoir Neuroscience.
“... potential to address the root causes of several neurological pathologies,” - Patrick Burgermeister, partner of Kizoo Technology Capital and new board member of Reservoir Neuroscience.
